Renal Cancers Terminated Phase 2 Trials for Durvalumab (DB11714)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02669914MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived TumorsTreatment